Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc. | 17 | 0 | 2 | 0 | €31.22 | €36.87 | 18.091% |
| Krystal Biotech | 17 | 0 | 1 | 0 | €166.80 | €182.46 | 9.388% |
| Esperion Therapeutis.Inc. | 16 | 1 | 1 | 0 | €1.86 | €10.00 | 438.938% |
| Medpace Holdings Inc | 16 | 0 | 4 | 0 | €354.30 | €418.12 | 18.014% |
| Molina Healthcare | 16 | 1 | 3 | 0 | €309.90 | €373.52 | 20.529% |
| Agilent Technologies Inc. | 16 | 4 | 1 | 0 | €125.38 | €133.94 | 6.830% |
| Geron Corp. | 16 | 0 | 2 | 0 | €4.29 | €5.55 | 29.403% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €40.00 | €46.28 | 15.694% |
| Repligen Corp. | 15 | 0 | 4 | 0 | €152.85 | €178.01 | 16.462% |
| Ocular Therapeutix Inc. | 15 | 4 | 2 | 0 | €7.63 | €13.09 | 71.506% |
| Laboratory Corp. Of America (labcorp) | 15 | 0 | 4 | 0 | €197.00 | €239.41 | 21.527% |
| PTC Therapeutics Inc. | 14 | 9 | 1 | 0 | €29.00 | €41.46 | 42.976% |
| Stoke Therapeutics Inc | 14 | 1 | 1 | 0 | €13.00 | €20.33 | 56.412% |
| CONMED Corp. | 14 | 2 | 4 | 1 | €61.50 | €98.42 | 60.029% |
| Henry Schein Inc. | 14 | 1 | 2 | 0 | €63.16 | €77.69 | 23.005% |
| Verastem Inc. | 14 | 0 | 3 | 0 | €2.16 | €16.61 | 669.167% |
| MacroGenics Inc. | 13 | 0 | 2 | 0 | €3.16 | €11.86 | 275.707% |
| Universal Health Services B | 13 | 6 | 2 | 1 | €197.00 | €178.72 | -9.280% |
| Amedisys Inc. | 13 | 0 | 0 | 0 | €88.00 | €92.26 | 4.841% |
| Rigel Pharmaceutical Inc. | 13 | 0 | 0 | 0 | €0.74 | €13.86 | 1772.365% |
| Catalyst Pharmaceutical Partners Inc | 13 | 0 | 1 | 0 | €16.76 | €25.69 | 53.272% |
| Twist Bioscience Corp | 13 | 2 | 2 | 2 | €40.25 | €41.76 | 3.752% |
| Staar Surgical Co. | 13 | 1 | 1 | 0 | €36.93 | €48.67 | 31.777% |
| Charles River Labs Intl | 13 | 0 | 2 | 0 | €184.05 | €247.61 | 34.533% |
| Incyte Corp. | 13 | 2 | 2 | 0 | €55.94 | €77.67 | 38.848% |